Benralizumab Patient Access Programme Study: Retrospective study in UK severe asthma centres

Trial Identifier:	D3250R00090
Sponsor:	AstraZeneca
NCTID::	NCT05932849
Start Date:	October 2021
Primary Completion Date:	February 2022
Study Completion Date:	February 2022
Condition:	Asthma

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
UK	Cambridge, UK
UK	Hull, UK
UK	Leeds, UK
UK	Liverpool, UK
UK	London, UK
UK	Southampton, UK

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.